OBJECTIVE: Unfair treatment may have a detrimental effect on cardiovascular health. However, little research on chronic health outcomes uses cumulative measures of unfair treatment. We tested whether cumulative unfair treatment was associated with greater subclinical cardiovascular disease in a diverse sample of African-American, Caucasian, Chinese, and Hispanic women. We also examined whether this relationship varied by race. METHOD: The Study of Women's Health Across the Nation is a longitudinal study of midlife women. Cumulative unfair treatment was calculated as the average of unfair treatment assessed over 10 years at 6 time points. Subclinical cardiovascular disease, specifically carotid intima media thickness and adventitial diameter, was assessed via carotid ultrasound conducted at study year 12 in 1,056 women. We tested whether cumulative unfair treatment was related to subclinical cardiovascular disease via linear regression, controlling for demographic factors including socioeconomic status and cardiovascular risk factors. RESULTS: The relation between unfair treatment and subclinical cardiovascular disease significantly varied by race (ps < .05), with unfair treatment related to higher intima media thickness (B = .03, SE = .01, p = .009) and adventitial diameter (B = .02, SE = .009, p = .013) only among Caucasian women. No significant relations between unfair treatment and subclinical cardiovascular disease outcomes were observed for African-American, Hispanic, and Chinese women. CONCLUSIONS: Our findings indicate that cumulative unfair treatment is related to worse subclinical cardiovascular disease among Caucasian women. These findings add to the growing literature showing that Caucasian women's experience of unfair treatment may have detrimental health implications. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
OBJECTIVE: Unfair treatment may have a detrimental effect on cardiovascular health. However, little research on chronic health outcomes uses cumulative measures of unfair treatment. We tested whether cumulative unfair treatment was associated with greater subclinical cardiovascular disease in a diverse sample of African-American, Caucasian, Chinese, and Hispanic women. We also examined whether this relationship varied by race. METHOD: The Study of Women's Health Across the Nation is a longitudinal study of midlife women. Cumulative unfair treatment was calculated as the average of unfair treatment assessed over 10 years at 6 time points. Subclinical cardiovascular disease, specifically carotid intima media thickness and adventitial diameter, was assessed via carotid ultrasound conducted at study year 12 in 1,056 women. We tested whether cumulative unfair treatment was related to subclinical cardiovascular disease via linear regression, controlling for demographic factors including socioeconomic status and cardiovascular risk factors. RESULTS: The relation between unfair treatment and subclinical cardiovascular disease significantly varied by race (ps < .05), with unfair treatment related to higher intima media thickness (B = .03, SE = .01, p = .009) and adventitial diameter (B = .02, SE = .009, p = .013) only among Caucasian women. No significant relations between unfair treatment and subclinical cardiovascular disease outcomes were observed for African-American, Hispanic, and Chinese women. CONCLUSIONS: Our findings indicate that cumulative unfair treatment is related to worse subclinical cardiovascular disease among Caucasian women. These findings add to the growing literature showing that Caucasian women's experience of unfair treatment may have detrimental health implications. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
Authors: Mercedes R Carnethon; Alain G Bertoni; Steven Shea; Philip Greenland; Hanyu Ni; David R Jacobs; Mohammed Saad; Kiang Liu Journal: Diabetes Care Date: 2005-11 Impact factor: 19.112
Authors: Tené T Lewis; Susan A Everson-Rose; Lynda H Powell; Karen A Matthews; Charlotte Brown; Kelly Karavolos; Kim Sutton-Tyrrell; Elizabeth Jacobs; Deidre Wesley Journal: Psychosom Med Date: 2006 May-Jun Impact factor: 4.312
Authors: Rebecca C Thurston; Samar R El Khoudary; Carol A Derby; Emma Barinas-Mitchell; Tené T Lewis; Candace K McClure; Karen A Matthews Journal: Stroke Date: 2014-02-27 Impact factor: 7.914
Authors: Lyn Kieltyka; Elaine M Urbina; Rong Tang; M Gene Bond; Sathanur R Srinivasan; Gerald S Berenson Journal: Atherosclerosis Date: 2003-09 Impact factor: 5.162
Authors: Andrea Leigh Stewart; Emma Barinas-Mitchell; Karen A Matthews; Samar R El Khoudary; Jared W Magnani; Elizabeth A Jackson; Maria M Brooks Journal: Psychosom Med Date: 2019 Nov/Dec Impact factor: 4.312
Authors: Elizabeth J Pantesco; Daniel K Leibel; Jason J Ashe; Shari R Waldstein; Leslie I Katzel; Hans B Liu; Nan-Ping Weng; Michele K Evans; Alan B Zonderman; Danielle L Beatty Moody Journal: Psychoneuroendocrinology Date: 2018-08-12 Impact factor: 4.905
Authors: Danielle L Beatty Moody; Daniel K Leibel; Taylor M Darden; Jason J Ashe; Shari R Waldstein; Leslie I Katzel; Hans B Liu; Nan-Ping Weng; Michele K Evans; Alan B Zonderman Journal: Biol Psychol Date: 2018-12-13 Impact factor: 3.251
Authors: Saad Samargandy; Karen A Matthews; Maria M Brooks; Emma Barinas-Mitchell; Jared W Magnani; Imke Janssen; Steven M Hollenberg; Samar R El Khoudary Journal: Arterioscler Thromb Vasc Biol Date: 2020-01-23 Impact factor: 8.311